Emis Group (LON: EMIS) shares are down 21% in London this morning on antitrust news. The problem is that the Competition and Markets Authority (CMA) in the UK has called in the bid for examination. Such processes take months, at the very least, to sort out. Bureaucracies do not, as we all know, move at the speed of markets or the business world.
The background is that United Health agreed to take over Emis back near a year in an all cash bid valued at £1.24 billion. As we can see from the share price chart below, this has been the support for the price all this time. Obviously so, if there's someone standing there willing to pay real cash for the entire issue then that's going to support the price of that share issue. The problem comes though with the possibility that the deal won't go through. Suddenly, if it isn't going to, then near a year's worth of potential share price changes then crystalise out into the one day. This is over and above the fact that the deal is delayed or possibly won't even be allowed to happen.
Emis Group share price from London Stock ExchangeThe announcement is here. The CMA first said that it was going to be looking into the transaction back in January. Yes, that is how long it takes the bureaucracy to wake up and decide to do something. We've also had a stage one decision that perhaps not, which Emis and United thought they had solved by agreeing to sell off one part of the newly to be joined companies. This wasn't acceptable to the CMA and so now here we are in this second stage. The CMA will not be swift in their work here, they never are. So, “options are being considered” and clearly that will include everything. Will the bid even be continued?
For us as traders or investors the thing to take away from this is that the business world - and stock markets - have become increasingly bureaucratised. Not only are decisions subject to review that review will be near interminable by the timescales of financial markets. That is, a cash bid is no longer necessarily cash in the bank.



